• AXIS Clinicals successfully completes 25th US FDA audit (November 2018)
  • AXIS Clinicals successfully completes 4th MHRA audit (June 2018)
  • AXIS Clinicals successfully completes 2nd WHO audit (December 2017)
  • AXIS Clinicals successfully completes AEMPS Spain (December 2018)
  • AXIS Clinicals successfully completes INFARMED Portugal (June 2018)
  • AXIS Clinicals successfully completes NPRA Malaysia (June 2018)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Our DNA

AXIS is an efficient, metric based clinical research provider with a global footprint of operations. Our mandate recognizes the need within the medical research community for quality clinical services backed by experience, ICH/GCP training, protocol adherence, and leadership at significant cost advantages. Representing a vertically integrated CRO, we provide a collaborative and personalized approach to meet sponsor study requirements.

Offering trial management and monitoring, quality assurance, regulatory submissions, data management and biostatistics, makes us the assembly of a functional team ideally suited for clinical study. Our clients have ranged from big pharma majors to the emerging biotechnology sector. Our customized billing models help us add new clients along with the retention of our recurring clientele.

With over 2,500 studies for various regulated markets, a huge data bank of validated bio-analytical methods for over 350 molecules and the facilities being inspected and approved by various global regulatory authorities, AXIS Clinicals ranks among the Top Clinical Research Organizations in India. As a Clinical Research Organization, our core competencies are in the realm of planning, designing and managing Clinical Trials - with clients that include national and international Pharmaceutical majors (innovators as well as generic pharmaceutical enterprises), Biotechnology and Medical Device organizations. Our clinical research programs employ the latest study designs in clinical pharmacology, Bio-Analytical method development and Pharmacokinetic analysis, conducted by a team of experienced and well-trained clinical coordinators and research associates.

AXIS Clinicals - A Promise to Precision in Clinical Research

 

Fact sheet

  • 2,600+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experienced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved